US President Donald Trump’s reliance on tariffs rather than sanctions has been described as both the “world’s worst bet” and ...

AstraZeneca Plc plans to invest $50 billion in the US before 2030, becoming the latest European pharma company to ratchet up ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

U.S. stock indexes inched their way to more records on Monday to kick off a week full of profit updates from big U.S. companies.

U.S. stocks are rising toward more records on Monday ahead of a week full of profit updates from big U.S. companies.

President Donald Trump has threatened tariffs on drugs coming from overseas, but it might take more than that to reroute the ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...